Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: The Hoorn study

Journal of Internal Medicine

Volumn 258, Issue 6, 2005, Pages 536-543

  Spoelstra De Man, A M E ^a,b   Smulders, Y M ^a,b   Dekker, J M ^c   Heine, R J ^c   Bouter, L M ^c   Nijpels, G ^c   Stehouwer, C D A ^a,c,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autonomic nervous system diseases; Diabetes mellitus type 2; Glucose metabolism disorders; Homocysteine; Hyperhomocysteinaemia

Indexed keywords

ANTIHYPERTENSIVE AGENT; HOMOCYSTEINE; INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC DYSFUNCTION; BREATHING; CARDIOVASCULAR FUNCTION; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG USE; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEART CYCLE; HEART RATE VARIABILITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RECUMBENCY; RISK FACTOR; SCORING SYSTEM; SEX; STANDING; STATISTICAL SIGNIFICANCE;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HEART RATE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INSULIN; MALE; MIDDLE AGED; SEX FACTORS; WAIST-HIP RATIO;

EID: 28244456468     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01578.x     Document Type: Article

References (33)

1. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288: 2015-22.
2. Hoogeveen EK, Kostense PJ, Jakobs C et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation 2000; 101: 1506-11.
3. Heart rate variability: standards of measurement, physiolo-gical interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-65.
4. O'Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 1991; 79: 495-502.
5. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10: 820-4.
6. Ambrosch A, Dierkes J, Lobmann R et al. Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med 2001; 18: 185-92.
7. Bisschops RH, van der Graaf GY, Mali WP, van der Grond GJ. Elevated levels of plasma homocysteine are associated with neurotoxicity. Atherosclerosis 2004; 174: 87-92.
8. Althausen S, Paschen W. Homocysteine-induced changes in mRNA levels of genes coding for cytoplasmic- and endoplasmic reticulum-resident stress proteins in neuronal cell cultures. Brain Res Mol Brain Res 2000; 84: 32-40.
9. Cohen JA, Jeffers BW, Stabler S, Schrier RW, Estascio R. Increasing homocysteine levels and diabetic autonomiec neuropathy. Auton Neurosci 2001; 87: 268-73.
10. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 1995; 38: 86-96.
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
12. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-79.
13. Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991; 565: 441-6.
14. Wesseling KH. A century of non-invasive arterial pressure measurement: Maley to Penaz and Finapress. Homeostasis 1995; 36: 50-66.
15. Gerritsen J, Dekker JM, TenVoorde BJ et al. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 2000; 43: 561-70.
16. Bendat JS, Piersol AG. Random Data Analysis and Measurement Procedures, 1st edn. New York: John Wiley and Sons, 1986.
17. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-8.
18. Faes TJ, De Neeling NN, Kingma R, TenVoorde BJ, Karemaker JM. On the quantification of heart rate changes in autonomic function tests: relations between measures in beats per minute, seconds and dimensionless ratios. Clin Sci 1995; 89: 557-64.
19. Mackay JD, Page MM, Cambridge J, Watkins PJ. Diabetic autonomic neuropathy. The diagnostic value of heart rate monitoring. Diabetologia 1980; 18: 471-8.
20. Ten Voorde BJ, Faes TJC, Janssen TJW, Scheffer GJ, Rompelman O. Respiratory modulation of blood pressure and heart rate studied with a computer model of baroreflex control. In: Computer Analysis of Cardiovascular Signals. 1995; Amsterdam, the Netherlands: IOS Press, 119-34.
21. Wieling W, van Brederode JF, de Rijk LG, Borst C, Dunning AJ. Reflex control of heart rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy. Diabetologia 1982; 22: 163-6.
22. Abdella NA, Mojiminiyi OA, Akanji AO, Moussa MA. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus. Acta Diabetol 2002; 39: 183-90.
23. Agullo-Ortuno MT, Albaladejo MD, Parra S et al. Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Clin Chim Acta 2002; 326: 105-12.
24. Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care 2000; 23: 1816-22.
25. Hoogeveen EK, Kostense PJ, Valk GD et al. Hyperhomocysteinaemia is not related to risk of distal somatic polyneuropathy: the Hoorn Study. J Intern Med 1999; 246: 561-6.
26. Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW. Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle Nerve 1998; 21: 72-80.
27. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999; 55: 1028-35.
28. Kleint V. Autonomic cardiac neuropathy in dialysis patients and kidney insufficiency patients. Z Gesamte Inn Med 1985; 40: 12-17.
29. Sanya EO, Ogunniyi A. Cardiovascular autonomic neuropathy in non-diabetic Nigerian patients with chronic renal failure. West Afr J Med 2004; 23: 15-20.
30. Tsai TJ, Chen YM, Chu TS, Wu CF, Tai TY. Cardiovascular autonomic dysfunction in non-insulin-dependent diabetes mellitus and its relation to renal dysfunction. J Formos Med Assoc 1993; 92: 509-13.
31. Gerritsen J, TenVoorde BJ, Dekker JM et al. Measures of cardiovascular autonomic nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects. Diabetologia 2003; 46: 330-8.
32. Pagani M, Lombardi F, Guzzetti S et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178-93.
33. Eckberg DL. Sympathovagal balance: a critical appraisal. Circulation 1997; 96: 3224-32.